0000927066-24-000024.txt : 20240223
0000927066-24-000024.hdr.sgml : 20240223
20240223174319
ACCESSION NUMBER: 0000927066-24-000024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ACKERMAN JOEL
CENTRAL INDEX KEY: 0001220630
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 24672868
MAIL ADDRESS:
STREET 1: COVENTRY HEALTH CARE, INC.
STREET 2: 6705 ROCKLEDGE DR SUITE 900
CITY: BETHESDA
STATE: MD
ZIP: 20817
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
DATE OF NAME CHANGE: 20121107
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
4
1
wk-form4_1708728174.xml
FORM 4
X0508
4
2024-02-21
0
0000927066
DAVITA INC.
DVA
0001220630
ACKERMAN JOEL
C/O DAVITA INC.
2000 16TH STREET
DENVER
CO
80202
0
1
0
0
CFO and Treasuer
0
Common Stock
2024-02-21
4
M
0
55000
52.41
A
178726
D
Common Stock
2024-02-21
4
D
0
23436
123
D
155290
D
Common Stock
2024-02-21
4
F
0
14930
123
D
140360
D
Stock Appreciation Rights
52.41
2024-02-21
4
M
0
55000
0
D
2022-06-20
2024-06-20
Common Stock
55000
55000
D
Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
The Stock Appreciation Rights were granted on June 20, 2019, which vested 50% each on June 20, 2022 and June 20, 2023.
/s/ Stephanie N. Berberich, Attorney-in-Fact
2024-02-23